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ABSTRACT
Exopolysaccharides (EPSs) are exocellular polymers present in the surface of many bacteria, including Lactobacillus and
Bifidobacterium. The genome sequence of several strains revealed the presence of EPS-encoding genes. However, the physi-
ological role that EPSs play in the bacterial ecology still remains uncertain. In this study, we have assessed the effect of EPSs
produced by Lactobacillus rhamnosus GG, Bifidobacterium longum NB667, and Bifidobacterium animalis IPLA-R1 on the
adhesion of probiotic and enteropathogen strains to human intestinal mucus. The EPS fraction GG had no significant effect
on the adhesion of L. rhamnosus GG and B. animalis IPLA-R1. However, the EPS fractions NB667 and IPLA-R1 significantly
reduced the adherence of both probiotic strains. In contrast, the three EPS fractions increased the adhesion of Enterobacter
sakazakii ATCC 29544 and Escherichia coli NCTC 8603. Higher adherence of Salmonella enterica serovar Typhimurium
ATCC 29631 and Clostridium difficile ATCC 9689 was detected in the presence of the EPS fractions GG and NB667. In
general, these effects were obtained at EPS concentrations of up to 5 mg/ml, and they were EPS dose dependent. The
competitive exclusion of probiotics in the presence of EPS could suggest the involvement of these biopolymers in the adhesion
to mucus. The increase in the adherence of enteropathogens could be explained if components of the pathogen surface are
able to bind to specific EPSs and the bound EPSs are able to adhere to mucus. To the best of our knowledge, this is the first
work reporting the effect of EPSs from probiotics on bacterial adhesion properties.
Probiotic has been defined as ‘‘a viable microbial food
supplement which beneficially influences the health of the
host’’ (29). Many of the health effects are related to the
capability of probiotic strains to adhere to the intestinal mu-
cosa. Therefore, this is one of the main criteria for the se-
lection of probiotic strains (5), although the mechanisms
and molecules involved in this process are not well known.
Carbohydrate moieties on the mucosal surface might be re-
sponsible for the adhesion of lactic acid bacteria, including
bifidobacteria (15, 17). Furthermore, strains of Lactobacil-
lus johnsonii, Lactobacillus reuteri, and Bifidobacterium
longum share mucosa carbohydrate-binding specificities
with enteropathogenic bacteria, such as Escherichia coli
and Helicobacter pylori (7, 14, 16). On the other hand, the
identities of the bacterial molecules involved in adhesion
of the probiotic bacteria are still not completely character-
ized. Some proteins from Lactobacillus species, which are
able to adhere to mucus components (8, 14, 24, 25), and a
mannose adhesion encoding gene from Lactobacillus plan-
tarum (20) have been identified. In addition, lipoteichoic
acids associated with the surface of L. johnsonii La1 also
participate in its adhesion to intestinal-like Caco-2 cells (9).
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There is considerably less information about the adhesion-
promoting molecules of Bifidobacterium. It has been sug-
gested that the adhesion determinants of bifidobacteria
could be glycoproteins or carbohydrate chains attached to
the cell wall (3). Bifidobacterium bifidum EB102 expresses
multiple proteinaceous components (still unidentified) on
the cell surface, which are able to bind Caco-2 glycolipids
(15). Some authors point to the hydrophobicity as an im-
portant factor for the adhesion properties of bifidobacteria
(4, 19). From these studies, it seems that multiple adherence
factors from the bacterial surface are responsible for the
adhesion of probiotic strains to the intestinal mucosa.
Exopolysaccharides (EPSs) are exocellular polymers
present in the surface of many lactic acid bacteria. A num-
ber of strains of Lactobacillus and Bifidobacterium, the
most common probiotics included in commercial products,
are able to produce these biopolymers (2, 11, 22, 23). Some
of the EPS-producing strains are currently used in the man-
ufacture of fermented dairy products as a source of natural
thickeners and stabilizing ingredients. Positive health ef-
fects have been attributed to EPSs (28). However, the phys-
iological role that these polymers play in the bacterial ecol-
ogy of probiotic lactic acid bacteria still remains uncertain.
It has been suggested that EPSs from other bacteria can act
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as protective agents against desiccation, antimicrobial com-
pounds, bacteriophage attack (6), and phagocytosis (12).
They can also be involved in adhesion to surfaces and bio-
film formation, such as oral biofilm (26).
Our aim in this study was to assess the effect of EPSs
produced by probiotic bacteria on bacterial adhesion to in-
testinal mucus. For this purpose, an immobilized human
intestinal mucus model was employed. The EPS fraction
produced by three probiotic strains was purified. The ad-
herence to intestinal mucus of two representative probiotic
strains, currently found in functional foods, and four enteric
pathogens was analyzed in the presence and absence of
these EPSs. To the best of our knowledge, this is the first
report on the effect of EPSs from probiotics on bacterial
adhesion properties.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Three EPS-pro-
ducing bacteria were used in this study: B. longum NB667, Bifi-
dobacterium animalis IPLA-R1 and Lactobacillus rhamnosus GG
(ATCC 53103). Strains were grown overnight at 37C in MRS
broth (Oxoid, Basingstoke, UK) containing 0.05% (wt/vol) L-cys-
teine (Sigma-Aldrich Finland, YA-Kemia Oy, Helsinki, Finland)
under aerobic conditions for L. rhamnosus GG and under anaer-
obic atmosphere (10% H2, 10% CO2, and 80% N2) in a Concept
400 anaerobic chamber (Ruskinn Technology, Leeds, UK) for bi-
fidobacteria. To obtain cellular biomass for EPS isolation, plates
of agar–MRS–cysteine were spread with 200 l of grown cultures
using sterile glass beads and incubated for 5 days at 37C. For
the adhesion experiments, fresh MRS–cysteine broth containing
10 l/ml tritiated thymidine ([5-3H]thymidine, 117 Ci/mM; Amer-
sham Biosciences, Buckinghamshire, UK) was inoculated at 1%
(vol/vol) with the cultures grown overnight and incubated as for-
merly indicated until the late-exponential phase. The enteric path-
ogens tested in this study were Clostridium difficile ATCC 9689,
Enterobacter sakazakii ATCC 29544, Salmonella enterica biovar
Typhimurium ATCC 29631, and E. coli NCTC 8603. Pathogenic
strains were grown overnight in Gifu anaerobic medium (GAM;
Nissui Pharmaceuticals, Japan) incubated at 37C in aerobic con-
ditions, except for C. difficile, which was incubated at the same
temperature anaerobically. These grown cultures were employed
to inoculate (1%, vol/vol) GAM medium containing 10 l/ml tri-
tiated thymidine. After incubation, radiolabeled probiotic and
pathogenic strains were harvested by centrifugation, washed twice
with N-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HE-
PES)–Hanks’ buffer (pH 7.4) (10 mM HEPES) (HH) and resus-
pended in HH buffer with and without different concentrations of
the isolated EPS fractions (1, 5, and 10 mg/ml). The A600 of the
bacterial suspensions was standardized to 0.25  0.01.
EPS isolation. Cellular biomass was collected from agar–
MRS–cysteine plates using 2 ml of ultrapure water and a plastic
L-shaped spreader. To release the polymer from the cell surface,
1 vol of 2 M NaOH was added to the cellular suspension and
stirred for 24 h at room temperature. Cells were removed by cen-
trifugation and EPSs from the supernatant were precipitated for
48 h at 4C using 2 volumes of absolute ethanol. The precipitated
EPS fraction obtained after centrifugation was resuspended in ul-
trapure water and dialyzed (3 days at 4C) against the same daily-
changed water using dialysis tubes (Sigma-Aldrich) of 12- to 14-
kDa molecular mass cutoff. Finally, the dialyzed EPS fractions
were freeze-dried. The protein content of the EPS fractions was
measured using the BCA protein assay kit (Pierce, Rockford, Ill.),
using bovine serum albumin (Sigma-Aldrich) as standard.
In vitro adhesion to human intestinal mucus. Mucus was
collected from the healthy part of human colonic tissue samples
obtained during surgery of patients with colon cancer as described
by Ouwehand et al. (18). Briefly, resected tissue was washed in
PBS containing 0.01% gelatine, and mucus was collected by gent-
ly scraping the mucosa with a rubber spatula. The mucus was
centrifuged to remove cell debris and bacteria and stored at
70C. Before use, the protein content was measured by the Low-
ry method (13) using bovine serum albumin as standard. Then,
mucus was dissolved in HH buffer at a concentration of 0.5 mg/
ml protein and stored at 20C before use. The adhesion of ra-
dioactively labeled probiotics and enteropathogens to immobilized
colonic mucus was assessed as described by Kirjavainen et al.
(10). In short, 100 l of intestinal mucus was immobilized on
polystyrene microtiter plate wells by overnight incubation at 4C.
Then, wells were washed twice with 200 l of HH buffer to re-
move the excess of mucus and filled with 100 l of the A600-
standardized (in HH buffer and in buffer containing EPS) radio-
labeled bacterial suspensions. After 1 h of incubation at 37C, the
wells were washed twice with HH buffer to remove the unattached
bacteria and the adhering cells were released and lysed with 200
l of lysis solution (1% [wt/vol] SDS in 0.1 M NaOH) at 60C
for 1 h. The content of wells was transferred to microfuge tubes
containing scintillation liquid (OptiPhase ‘‘HiSafe 3,’’ Wallac Oy,
Turku, Finland) and the radioactivity of lysed bacteria was deter-
mined by liquid scintillation with a 1450 Microbeta Liquid Scin-
tillation Counter (Wallac). Adhesion results were expressed as the
percentage of radioactivity recovered after adhesion relative to the
radioactivity of the bacterial suspension initially added to the im-
mobilized mucus.
Statistical analysis. At least two replicated experiments,
each done in triplicate, were carried out in all adhesion assays.
Data obtained for each microorganism tested were statistically an-
alysed by means of one-way analysis of variance (ANOVA) using
the SPSS 11.0 software for Windows (SPSS, Chicago, Ill.). The
‘‘EPS concentration’’ was used as factor and the differences be-
tween the EPS concentrations were assessed by the least-signifi-
cant difference (LSD) comparison of means test at a significance
level of P  0.05.
RESULTS AND DISCUSSION
The percentage of protein content of the isolated EPS
fractions was 6.08  0.65, 4.49  0.63, and 6.93  2.26
for fractions GG, NB667, and IPLA-R1, respectively.
Thereby, the major content of our fractions was EPS poly-
mer with a molecular mass higher than 1.2 	 105 Da which
was the cutoff size of the dialysis membrane used. Our EPS
polymers had a molecular mass included in the range de-
scribed previously for EPSs of different origins (from 2.5
	 104 to 2.2 	 107) (27). The preliminary results obtained
by gas chromatography–mass spectrometry about the qual-
itative composition of the EPS fractions from the two bi-
fidobacteria strains used in our study indicated that the main
constituent monosaccharides are glucose, galactose, and
rhamnose present in different ratios (data not shown). The
structure of the repeating unit that built the EPS-GG has
been reported previously (11) and is a hexasaccharide com-
posed of four molecules of galactose, one rhamnose, and
one N-acetyl-glucosamine.
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FIGURE 1. Adhesion of L. rhamnosus GG
(I) and B. animalis IPLA-R1 (II) to human
intestinal mucus in the presence of increas-
ing concentrations of the EPS fractions
GG (a), NB667 (b), and IPLA-R1 (c). EPS
concentrations: , 0; r, 1; h, 5; and ,
10 mg/ml. Bars within the same plot that
do not share equal letters are significantly
different (P  0.05).
The effect of the three EPSs tested in the adhesion of
two representative probiotic strains (L. rhamnosus GG and
B. animalis IPLA-R1) is presented in Figure 1. Results
showed that the adhesion levels varied in the presence of
EPS, the effect being EPS type dependent. The EPS frac-
tion GG showed no effect in the adhesion of L. rhamnosus
GG and a slight increase in the adherence of B. animalis
IPLA-R1 at the highest dose. However, the EPS fractions
NB667 and IPLA-R1 promoted a significant reduction in
the adhesion of both probiotic strains. At a concentration
of 10 mg/ml, this effect was more pronounced for the EPS
fraction NB667 (adhesion decrease of 66 and 60% for L.
rhamnosus GG and B. animalis IPLA-R1, respectively)
than for the EPS fraction IPLA-R1 (24 and 18%, respec-
tively). Moreover, a significant (P  0.001) reduction in
the adhesion of the Lactobacillus strain was obtained from
the lowest dose of the EPS fraction NB667 tested (1 mg/
ml), whereas the minimum effective dose of the EPS frac-
tion IPLA-R1 for both probiotics was 5 mg/ml. These facts
suggest that the different physicochemical and/or structural
characteristics of the three biopolymers could account for
their differential effect in probiotic adhesion. The reduction
of adhesion in the presence of EPS fractions NB667 and
IPLA-R1 was higher for L. rhamnosus GG than for B. an-
imalis IPLA-R1. Therefore, the surface characteristics of
the probiotic strains could also contribute to the differences
in adhesion. The results obtained point to the involvement
of the EPSs produced by probiotic strains in their adhesion
to the intestinal mucus. The polymers could directly adhere
to intestinal mucus and then competitively inhibit the ad-
hesion of the probiotics (Fig. 2a), or they could stick to the
probiotic surface and thereby mask the bacterial molecules
involved in adhesion (Fig. 2b).
The three EPSs under study also modified the adhesion
of the enteropathogens analyzed (Table 1). The EPS frac-
tions GG and NB667 increased the adhesion of three out
of the four pathogens studied. However, the EPS fraction
IPLA-R1 had no effect on C. difficile and S. enterica ser-
ovar Typhimurium, but enhanced the adhesion of E. saka-
zakii and E. coli. In general, all these effects were detected
at EPS doses higher than 5 mg/ml. With respect to Clos-
tridium and Salmonella, which showed low adherence to
mucus (around 3%), the adhesion was only influenced by
one EPS fraction. The adherence of Enterobacter and Esch-
erichia, with higher adhesion values, was modified by the
three EPSs analyzed. The maximum increase of adherence
was detected at 10 mg/ml for E. sakazakii in the presence
of the EPS fraction NB667 (61%) and for E. coli with the
EPS fraction GG (82%). Similar to that found with pro-
biotic strains, the modification of the adhesion properties
of pathogens by the EPSs was dependent on the EPS type
and the pathogen tested. These results suggest that com-
ponents of the pathogen surface might bind specific EPSs
and the bound EPS would be able to adhere to mucus (Fig.
2c).
The results obtained in the present work indicate that
the EPSs produced by probiotic strains could be able to
adhere to intestinal mucus, the effect being dose and EPS
type dependent. The genome sequence of probiotic Lacto-
bacillus and Bifidobacterium strains predicts the occurrence
of proteins needed for the production of glycoprotein-bind-
ing fimbriae and mucus- and fibronectin-binding proteins
that could be involved in the bacterial adhesion to the gas-
trointestinal tract (1, 21, 30). This could reflect the adap-
tation of probiotics to their natural environment. Very often
in the sequence of these genomes, genetic determinants for
the synthesis of EPSs are also found (1, 21, 30). Thereby,
both proteins and EPSs could act as adherence factors that
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FIGURE 2. Putative explanation of the in-
terference of EPSs on the adhesion of pro-
biotics and pathogens to intestinal mucus.
Decrease of probiotic adhesion: (a) EPS
could directly adhere to mucus and then
competitively inhibit the adhesion of pro-
biotics or (b) they could stick to the pro-
biotic surface and thereby mask bacterial
molecules involved in adhesion. Increase
of pathogen adhesion: (c) components of
the pathogen surface might bind specific
EPSs and the bound EPS would be able to
adhere to mucus.
TABLE 1. Percentage of adhesion to human intestinal mucus of enteropathogenic strains in the presence of increasing concentrations
of the EPS fractions GG, NB667, and IPLA-R1 isolated from the strains L. rhamnosus GG, B. longum NB667, and B. animalis IPLA-
R1, respectively
EPS fraction
EPS
concn
(mg/ml)
% adhesion (mean  SD)a
C. difficile
ATCC 9689
E. sakazakii
ATCC 29544
E. coli
NCTC 8603
Salmonella
Typhimurium
ATCC 29631
EPS-GG 0
1
5
10
2.73  1.05
2.58  0.36
3.17  0.85
3.11  0.31
9.52  1.52 A
10.68  0.52 AB
11.70  1.91 B
13.65  1.47 C
6.79  1.04 A
7.56  1.94 AB
8.82  1.79 B
12.33  2.53 C
1.91  0.82 A
2.05  0.41 A
3.13  0.87 B
3.09  0.47 B
***b *** **
EPS-NB667 0
1
5
10
1.44  0.34 A
1.75  0.14 A
1.91  0.34 B
2.29  0.23 C
***
4.63  1.53 A
6.24  2.40 A
7.49  1.81 B
7.46  2.60 B
*
4.37  0.55 A
4.56  0.83 AB
5.59  1.79 B
5.90  2.25 B
**
1.65  0.43
1.43  0.29
2.04  0.48
2.01  0.72
EPS-IPLA-R1 0
1
5
10
1.66  0.68
2.66  1.60
2.77  0.80
2.67  1.40
5.27  0.72 A
5.39  1.46 A
6.38  1.22 A
7.83  0.46 B
***
4.37  0.57 A
4.51  0.67 A
5.29  1.02 C
4.53  1.67 B
***
1.72  0.36
2.34  0.77
1.79  0.26
2.38  0.49
a Columns with different letters are significantly different (P  0.05) according to the test of means comparison LSD.
b One-way ANOVA: * P  0.05, ** P  0.01, *** P  0.001.
may play a role in the transitory colonization of the intes-
tinal mucosa by probiotics. As far as we know, data are not
currently available in the literature dealing with the pro-
duction of EPSs by probiotics under the gastrointestinal
tract conditions, nor data for EPS concentration from bac-
terial origin in this location. However, the ubiquity of EPS
gene clusters on probiotic genomes allows us to suggest
that a number of strains from the intestinal microbiota may
produce extracellular polymers in this environment and that
high EPS concentrations could be locally reached in the
gastrointestinal tract. A future challenge would be the de-
termination of EPS concentration in the gastrointestinal
tract and the effect of these polymers in the in vivo adher-
ence of bacteria. On the other hand, more studies about the
chemical composition, the structure of the EPSs produced
by probiotics, and their relationship to the bacterial adhe-
sion are needed in order to propose a mechanism of action
for these biopolymers.
J. Food Prot., Vol. 69, No. 8 EXOPOLYSACCHARIDES INTERFERE WITH BACTERIAL ADHESION TO MUCUS 2015
ACKNOWLEDGMENTS
This work was financed by European Union FEDER funds and the
Spanish Plan Nacional de ID (Project AGL2004-06088-CO2-01) and the
Akademy of Finland. P. Ruas-Madiedo was supported by an I3P postdoc-
toral research contract granted by CSIC and FEDER funds.
REFERENCES
1. Altermann, E., W. M. Russell, M. A. Azcarate-Peril, R. Barrangou,
B. L. Buck, O. McAuliffe, N. Shouther, A. Dobson, T. Duong, M.
Callanan, S. Lick, A. Hamrick, R. Cano, and T. R. Klaenhammer.
2005. Complete genome sequence of the probiotic lactic acid bac-
terium Lactobacillus acidophilus NCFM. Proc. Natl. Acad. Sci. USA
102:3906–3912.
2. Andaloussi, S. A., H. Talbaoui, R. Marczak, and R. Bonaly. 1995.
Isolation and characterization of exocellular polysaccharides pro-
duced by Bifidobacterium longum. Appl. Environ. Biotechnol. 43:
995–1000.
3. Bibiloni, R., P. F. Pe´rez, and G. L. de Antoni. 1999. Factors involved
in adhesion of bifidobacterial strains to epithelial cells in culture.
Anaerobe 5:483–485.
4. Del Re, B., B. Sgorbati, M. Miglioli, and D. Palenzona. 2000. Ad-
hesion, autoaggregation and hydrophobicity of 13 stains of Bifido-
bacterium longum. Lett. Appl. Microbiol. 31:438–442.
5. Dunne, C., L. O’Mahony, L. Murphy, G. Thornton, D. Morrissey,
S. O’Halloran, M. Feeny, S. Flynn, G. Fitzgerald, C. Daly, B. Kiely,
G. C. O’Sullivan, F. Shanahan, and J. K. Collins. 2001. In vitro
selection criteria for probiotic bacteria of human origin: correlation
with in vivo findings. Am. J. Clin. Nutr. 73:386S–392S.
6. Forde, A., and G. F. Fitzgerald. 1999. Analysis of exopolysacchari-
des (EPS) production mediated by the bacteriophage adsorption
blocking plasmid, pCI658, isolated from Lactococcus lactis ssp. cre-
moris HO2. Int. Dairy J. 9:465–472.
7. Fujiwara, S., H. Hashiba, T. Hirota, and J. F. Forstner. 2001. Inhi-
bition of the binding of enterotoxigenic Escherichia coli Pb176 to
human intestinal epithelial cell line HCT-18 by an extracellular pro-
tein fraction containing BIF of Bifidobacterium longum SBT2928:
suggestive evidence of blocking of the binding receptor gangliote-
traosylceramide on the cell surface. Int. J. Food Microbiol. 67:97–
106.
8. Granato, D., G. E. Bergonzelli, R. D. Pridmore, L. Marvin, M. Rou-
vet, and I. E. Corthe´sy-Theulaz. 2004. Cell surface-associated elon-
gation factor Tu mediates the attachment of Lactobacillus johnsonii
NCC533 (La1) to human intestinal cells and mucins. Infect. Immun.
72:2160–2169.
9. Granato, D., F. Perotti, I. Masserey, M. Rouvet, M. Golliard, A.
Sevin, and D. Brassart. 1999. Cell surface-associated lipoteichoic
acid acts as an adhesion factor for attachment of Lactobacillus john-
sonii La1 to human enterocyte-like CaCo-2 cells. Appl. Environ. Mi-
crobiol. 65:1071–1077.
10. Kirjavainen, P. E., A. C. Ouwehand, E. Isolauri, and S. Salminen.
1998. The ability of probiotic bacteria to bind to human intestinal
mucus. FEMS Microbiol. Lett. 167:185–189.
11. Landersjo¨, C., Z. Yang, E. Huttunen, and G. Widmalm. 2002. Struc-
tural studies of the exopolysaccharides produced by Lactobacillus
rhamnosus strain GG (ATCC 53103). Biomacromolecules 3:880–
884.
12. Lo´pez, R., and E. Garcı´a. 2004. Recent trends on the molecular
biology of pneumococcal capsules, lytic enzymes, and bacterio-
phage. FEMS Microbiol. Rev. 28:553–580.
13. Lowry, O. H., H. J. Rosenbourgh, A. L. Farr, and R. J. Randall.
1951. Protein measurement with the Folin phenol reagent. J. Biol.
Chem. 19:265–275.
14. Mukai, T., T. Asasaka, E. Sato, K. Mori, M. Matsumoto, and H.
Ohori. 2002. Inhibition of binding of Helicobacter pylori to the gly-
colipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol.
Med. Microbiol. 32:105–110.
15. Mukai, T., S. Kaneko, M. Matsumoto, and H. Ohori. 2004. Binding
of Bifidobacterium bifidum and Lactobacillus reuteri to the carbo-
hydrate moieties of intestinal glycolipids recognized by peanut ag-
glutinin. Int. J. Food Microbiol. 90:357–362.
16. Neeser, J. R., D. Granto, M. Rouvet, A. Servin, S. Teneberg, and K.
A. Karlsson. 2000. Lactobacillus johnsonii La1 share carbohydrate-
binding specificities with several enteropathogenic bacteria. Glyco-
biology 10:1193–1199.
17. Ouwehand, A. C., E. Isolauri, P. V. Kirjavanien, and S. J. Salminen.
1999. Adhesion of four Bifidobacterium strains to human intestinal
mucus from subjects in different age groups. FEMS Microbiol. Lett.
172:61–64.
18. Ouwehand, A. C., S. Salminen, S. To¨lkko¨, P. Roberts, J. Ovaska,
and E. Salminen. 2002. Resected human colonic tissue: new model
for characterizing adhesion of lactic acid bacteria. Clin. Diagn. Lab.
Immunol. 9:184–186.
19. Pe´rez, P. F., Y. Minnaard, E. A. Disalvo, and G. L. de Antoni. 1998.
Surface properties of bifidobacterial strains of human origin. Appl.
Environ. Microbiol. 64:21–26.
20. Pretzer, G., J. Snel, D. Molenaar, A. Wiersma, P. A. Bron, J. Lambert,
W. M. de Vos, R. van der Meer, M. A. Smits, and M. Kleerebezem.
2005. Biodiversity-based identification and functional characteriza-
tion of the mannose-specific adhesin of Lactobacillus plantarum. J.
Bacteriol. 187:6128–6136.
21. Pridmore, R. D., B. Berger, F. Desiere, D. Vilanova, C. Barretto, A.
C. Pittet, M. C. Zwahlen, M. Rouvet, E. Altermann, R. Barrangou,
B. Mollet, A. Mercenier, T. Klaenhammer, F. Arigoni, and M. Schell.
2004. The genome sequence of the probiotic intestinal bacterium
Lactobacillus johnsonii NCC 533. Proc. Natl. Acad. Sci. USA 101:
2512–2517.
22. Roberts, C. M., W. F. Fett, S. F. Osman, C. Wijey, J. V. OConnor,
and D. G. Hoover. 1995. Exopolysaccharide production by Bifido-
bacterium longum BB-79. J. Appl. Bacteriol. 78:463–468.
23. Robijn, G. W., R. G. Gallego, D. J. C. van den Berg, H. Haas, J. P.
Kamerling, and J. F. G. Vliegenthart. 1996. Structural characteriza-
tion of the exopolysaccharide produced by Lactobacillus acidophilus
LMG9433. Carbohydr. Res. 288:203–218.
24. Rojas, M., F. Ascencio, and P. L. Conway. 2002. Purification and
characterization of a surface protein from Lactobacillus fermentum
104R that binds to porcine small intestinal mucus and gastric mucin.
Appl. Environ. Microbiol. 68:2330–2336.
25. Roos, S., and H. Jonsson. 2002. A high-molecular-mass cell-surface
protein from Lactobacillus reuteri 1063 adheres to mucus compo-
nents. Microbiology 148:433–442.
26. Rozen, R., D. Steinberg, and G. Bachrach. 2004. Streptococcus mu-
tans fructosyltransferase interactions with glucans. FEMS Microbiol.
Lett. 232:39–43.
27. Ruas-Madiedo, P., and C. G. de los Reyes-Gavila´n. 2005. Invited
review: methods for the screening, isolation, and characterization of
exopolysaccharides produced by lactic acid bacteria. J. Dairy Sci.
88:843–856.
28. Ruas-Madiedo, P., J. Hugenholtz, and P. Zoon. 2002. An overview
of the functionality of exopolysaccharides produced by lactic acid
bacteria. Int. Dairy J. 12:163–171.
29. Salminen, S., C. Bouley, M. C. Bouton-Ruault, J. H. Cummings, A.
Franck, G. R. Gibson, E. Isolauri, M. C. Moreau, M. Roberfroid,
and I. Rowland. 1998. Functional food science and gastrointestinal
physiology and function. Br. J. Nutr. 80(Suppl. 1):S147–S171.
30. Schell, M. A., M. Karmirantzou, B. Snel, D. Vilanova, B. Berger,
G. Pessi, M. C. Zwahlen, F. Desiere, P. Bork, M. Delley, R. D.
Pridmore, and F. Arigoni. 2002. The genome sequence of Bifidobac-
terium longum reflects its adaptation to human gastrointestinal tract.
Proc. Natl. Acad. Sci. USA 99:14422–14427.
